We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+5.9%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$65.3B
AUM Growth
-$12.5B
Cap. Flow
-$2.47B
Cap. Flow %
-3.79%
Top 10 Hldgs %
10.68%
Holding
4,408
New
448
Increased
1,171
Reduced
1,784
Closed
828

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.38%
2 Energy 10.34%
3 Technology 9.79%
4 Consumer Discretionary 9.73%
5 Healthcare 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUNR
2401
DELISTED
Qunar Cayman Islands Limited
QUNR
$1.2M ﹤0.01%
+28,999
New +$884K
FCB
2402
DELISTED
FCB Financial Holdings, Inc.
FCB
$1.19M ﹤0.01%
+43,622
New +$1.07M
OIS icon
2403
PUT
Oil States International
OIS
$506M
$1.19M ﹤0.01%
+30,000
New +$1.27M
SILC icon
2404
Silicom
SILC
$265M
$1.19M ﹤0.01%
+28,755
New +$1.2M
USCR
2405
DELISTED
U S Concrete, Inc.
USCR
$1.19M ﹤0.01%
35,086
+12,703
+57% +$376K
ASCMA
2406
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$1.19M ﹤0.01%
29,812
+20,596
+223% +$916K
LAMR icon
2407
CALL
Lamar Advertising Co
LAMR
$15.3B
$1.19M ﹤0.01%
20,000
-65,000
-76% -$3.71M
CE icon
2408
Celanese
CE
$4.89B
$1.18M ﹤0.01%
21,192
-32,853
-61% -$1.86M
NVS icon
2409
Novartis
NVS
$294B
$1.18M ﹤0.01%
+13,392
New +$1.19M
REG icon
2410
Regency Centers
REG
$13.9B
$1.18M ﹤0.01%
17,391
-136,416
-89% -$9.17M
LEAF
2411
DELISTED
Leaf Group Ltd.
LEAF
$1.18M ﹤0.01%
206,773
+19,446
+10% +$99.7K
OPB
2412
DELISTED
Opus Bank Common Stock
OPB
$1.18M ﹤0.01%
38,312
+29,189
+320% +$826K
PBI icon
2413
CALL
Pitney Bowes
PBI
$2.38B
$1.18M ﹤0.01%
50,700
-88,400
-64% -$2.06M
PHIIK
2414
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$1.18M ﹤0.01%
39,304
-1,794
-4% -$59.8K
VRTX icon
2415
CALL
Vertex Pharmaceuticals
VRTX
$139B
$1.18M ﹤0.01%
10,000
-6,900
-41% -$827K
CSIQ icon
2416
PUT
Canadian Solar
CSIQ
$953M
$1.18M ﹤0.01%
35,200
-50,000
-59% -$1.38M
SBAC icon
2417
CALL
SBA Communications
SBAC
$19.8B
$1.17M ﹤0.01%
10,000
OSIR
2418
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$1.17M ﹤0.01%
66,604
+52,818
+383% +$887K
RAX
2419
DELISTED
Rackspace Hosting Inc
RAX
$1.17M ﹤0.01%
+22,663
New +$1.11M
CKP
2420
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$1.17M ﹤0.01%
108,066
+22,454
+26% +$285K
BBSI icon
2421
Barrett Business Services
BBSI
$831M
$1.17M ﹤0.01%
+108,896
New +$987K
WKC icon
2422
World Kinect Corp
WKC
$1.84B
$1.17M ﹤0.01%
20,273
-23,452
-54% -$1.22M
NSIT icon
2423
Insight Enterprises
NSIT
$4.59B
$1.16M ﹤0.01%
40,598
+15,370
+61% +$396K
ADM icon
2424
PUT
Archer Daniels Midland
ADM
$38.4B
$1.16M ﹤0.01%
24,400
-100,400
-80% -$4.78M
OEC icon
2425
Orion
OEC
$350M
$1.16M ﹤0.01%
64,257
+36,417
+131% +$619K

Similar funds

David Shaw's Q1 2015 Portfolio in Review

As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

David Shaw withdrew a net $2.47B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 36% a quarter earlier, followed by Energy and Technology.

Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.

  • David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
  • David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
  • David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
  • David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
  • David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
  • David Shaw opened 448 new positions and closed 828 in Q1 2015.
  • David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.